Скачать или смотреть How family support helped Brandon's journey

Brandon shares how his family made sure he had everything he needed throughout his cancer journey.

Official video for ADCETRIS® (brentuximab vedotin) for injection. This video is intended for US residents 18 or older and is intended to be viewed in the context of its original location. The video is for educational purposes only and is not intended to replace discussions with a healthcare provider. See Select Safety Information below, including BOXED WARNING, and Important Facts: https://www.pfi.sr/if

SELECT SAFETY INFORMATION
ADCETRIS can cause serious side effects, including a rare, serious brain infection called progressive multifocal leukoencephalopathy (PML) that can lead to death. Tell your doctor immediately if you have mood or behavior changes, confusion, problems in thinking or loss of memory, changes in vision, speech, or walking, or decreased strength or weakness on one side of the body.

Do not take ADCETRIS if you are receiving bleomycin.

ADCETRIS can cause other serious side effects, including:

Nerve damage (peripheral neuropathy). Tell your doctor if you have any numbness or tingling in your hands or feet or any muscle weakness.

Allergic and infusion reactions. Tell your doctor if you experience symptoms of fever, chills, rash, or breathing problems within 24 hours of infusion.

Blood problems. Serious cases, including death, of fever with a low number of white blood cells have occurred with ADCETRIS. Serious cases of a low number of white blood cells, a low number of platelets, or a low number of red blood cells can occur.

Serious infections have been reported.

Tumor lysis syndrome (TLS).

ADCETRIS patients with severe kidney problems or moderate or severe liver problems may have more side effects and deaths than patients without kidney or liver problems.

Liver problems. Serious liver problems, including death, can occur.

Lung problems. Serious lung problems, including death, can occur.

Skin problems. Rare but serious skin conditions, including death, can occur.

Gastrointestinal (GI) problems. Serious problems, including death, related to the pancreas, stomach, intestine, and colon, can occur.

High blood sugar (hyperglycemia).

The most common side effects (≥20%) in adult patients who received ADCETRIS are: nerve damage (peripheral neuropathy, nausea, feeling tired, muscle pain, constipation, diarrhea, vomiting, fever, infection in the nose or sinuses, sores or swelling in the mouth and/or in the digestive tract, upper stomach pain, rash.
The most common laboratory abnormalities (≥20%) in adult patients who received ADCETRIS are: a decrease in white blood cells, an increase in creatinine, a decrease in hemoglobin, an increase in blood sugars. an increase in alanine aminotransferase (ALT), an increase of aspartate aminotransferase (AST).
The most common severe side effects (≥5%) in pediatric patients who received ADCETRIS are: a low number of white blood cells. a low number of red blood cells, a low number of platelets, fever with a low number of white blood cells, sores or swelling in the mouth, infection.

These are not all the possible side effects of ADCETRIS. Tell your doctor about any side effect that bothers you or does not go away. If you have certain side effects, your doctor may lower your dose, delay, or stop your ADCETRIS treatment.

Before receiving ADCETRIS, tell your doctor:


All your medical conditions, including if you have kidney, liver, or lung problems, an infection, or diabetes.

If you are pregnant or plan to become pregnant. ADCETRIS may harm your unborn baby. Females who are able to become pregnant: Your doctor should give you a pregnancy test before starting ADCETRIS treatment. You should use effective birth control during ADCETRIS treatment and for 2 months after your last dose of ADCETRIS. Tell your doctor right away if you become pregnant or think you are pregnant during ADCETRIS treatment. Men with female partners who can get pregnant should use effective birth control during ADCETRIS treatment and for 4 months after the last dose.

If you are breastfeeding or plan to breastfeed. Do not breastfeed during ADCETRIS treatment.

All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ADCETRIS and certain other medicines can affect each other.


This is only a summary of important information about ADCETRIS. Talk to your healthcare provider to learn more or go to adcetris.com for Important Facts about ADCETRIS.


You are encouraged to directly report adverse events by calling 1-800-438-1985 (US only) or by contacting the FDA directly at fda.gov/MedWatch or call 1-800-FDA-1088.


ADCETRIS and its logo are US registered trademarks of Seagen Inc.
© 2025 Pfizer Inc. All rights reserved.
May 2025. PP-A1T-USA-0883.